PET response and FFS in NHL and HL
| Diagnosis, PET . | No. of patients . | Relapse rate, no. (%) . | P . | 2-y FFS, % (95% CI) . | P . |
|---|---|---|---|---|---|
| NHL | < .001 | < .001 | |||
| CR | 19 | 5 (26) | 72 (60-81) | ||
| PR | 36 | 22 (61) | 38 (30-46) | ||
| NR | 23 | 20 (87) | 10 (4-16) | ||
| HL | .14 | .45 | |||
| CR | 8 | 2 (25) | 73 (57-89) | ||
| PR | 10 | 7 (70) | 37 (21-53) | ||
| NR | 5 | 3 (60) | 40 (18-62) |
| Diagnosis, PET . | No. of patients . | Relapse rate, no. (%) . | P . | 2-y FFS, % (95% CI) . | P . |
|---|---|---|---|---|---|
| NHL | < .001 | < .001 | |||
| CR | 19 | 5 (26) | 72 (60-81) | ||
| PR | 36 | 22 (61) | 38 (30-46) | ||
| NR | 23 | 20 (87) | 10 (4-16) | ||
| HL | .14 | .45 | |||
| CR | 8 | 2 (25) | 73 (57-89) | ||
| PR | 10 | 7 (70) | 37 (21-53) | ||
| NR | 5 | 3 (60) | 40 (18-62) |